Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuaki Ochi

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
Molecular Cancer Therapeutics|February 28, 2013
Afatinib prolongs survival compared with gefitinib in an epidermal growth factor receptor-driven lung cancer modelTakashi Ninomiya, Nagio Takigawa, Eiki Ichihara, et al.
Lung Cancer (Amsterdam, Netherlands)|November 19, 2013
Effect of AZD1480 in an epidermal growth factor receptor-driven lung cancer modelToshi Murakami, Nagio Takigawa, Takashi Ninomiya, et al.
Anticancer Research|November 29, 2025
Co-expression of PD1/PD-L1 on Tumor Cells Is Involved in the Regulation of Cell ProliferationYasunari Nagasaki, Hiromichi Yamane, Masami Takeyama, et al.
Drug Design, Development and Therapy|January 14, 2015
Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulationNobuaki Ochi, Hiromichi Yamane, Katsuyuki Hotta, et al.
Journal of Personalized Medicine|August 27, 2025
Influence of Primary Care Physicians on End-of-Life Treatment Choices in Lung Cancer Diagnosed in the Emergency DepartmentTatsuyuki Kawahara, Nobuaki Ochi, Hirohito Kirishi, et al.
Experimental Cell Research|April 29, 2014
Everolimus prolonged survival in transgenic mice with EGFR-driven lung tumorsMasayuki Yasugi, Nagio Takigawa, Nobuaki Ochi, et al.
Therapeutics and Clinical Risk Management|June 11, 2021
IgA Vasculitis in a Lung Cancer Patient During ChemoradiotherapyMasataka Taoka, Nobuaki Ochi, Ayaka Mimura, et al.
Thoracic Cancer|December 29, 2021
Short-term safety of an anti-severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine for patients with advanced lung cancer treated with anticancer drugs: A multicenter, prospective, observational studyTomoki Tamura, Kiichiro Ninomiya, Toshio Kubo, et al.
Acta Medica Okayama|December 23, 2011
Successful extracorporeal life support for life-threatening hypercapnia with bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantationKoichi Waseda, Yasushi Tanimoto, Shingo Ichiba, et al.
Thoracic Cancer|November 20, 2022
Safety of anti-SARS-CoV-2 messenger RNA vaccine in lung cancer patients undergoing anticancer chemotherapy: A multicenter, prospective, observational, patient-reported outcome studyDaijiro Harada, Tomoki Tamura, Kiichiro Ninomiya, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Molecular Cancer Therapeutics|February 28, 2013
Afatinib prolongs survival compared with gefitinib in an epidermal growth factor receptor-driven lung cancer modelTakashi Ninomiya, Nagio Takigawa, Eiki Ichihara, et al.
Lung Cancer (Amsterdam, Netherlands)|November 19, 2013
Effect of AZD1480 in an epidermal growth factor receptor-driven lung cancer modelToshi Murakami, Nagio Takigawa, Takashi Ninomiya, et al.
Anticancer Research|November 29, 2025
Co-expression of PD1/PD-L1 on Tumor Cells Is Involved in the Regulation of Cell ProliferationYasunari Nagasaki, Hiromichi Yamane, Masami Takeyama, et al.
Drug Design, Development and Therapy|January 14, 2015
Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulationNobuaki Ochi, Hiromichi Yamane, Katsuyuki Hotta, et al.
Journal of Personalized Medicine|August 27, 2025
Influence of Primary Care Physicians on End-of-Life Treatment Choices in Lung Cancer Diagnosed in the Emergency DepartmentTatsuyuki Kawahara, Nobuaki Ochi, Hirohito Kirishi, et al.
Experimental Cell Research|April 29, 2014
Everolimus prolonged survival in transgenic mice with EGFR-driven lung tumorsMasayuki Yasugi, Nagio Takigawa, Nobuaki Ochi, et al.
Therapeutics and Clinical Risk Management|June 11, 2021
IgA Vasculitis in a Lung Cancer Patient During ChemoradiotherapyMasataka Taoka, Nobuaki Ochi, Ayaka Mimura, et al.
Thoracic Cancer|December 29, 2021
Short-term safety of an anti-severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine for patients with advanced lung cancer treated with anticancer drugs: A multicenter, prospective, observational studyTomoki Tamura, Kiichiro Ninomiya, Toshio Kubo, et al.
Acta Medica Okayama|December 23, 2011
Successful extracorporeal life support for life-threatening hypercapnia with bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantationKoichi Waseda, Yasushi Tanimoto, Shingo Ichiba, et al.
Thoracic Cancer|November 20, 2022
Safety of anti-SARS-CoV-2 messenger RNA vaccine in lung cancer patients undergoing anticancer chemotherapy: A multicenter, prospective, observational, patient-reported outcome studyDaijiro Harada, Tomoki Tamura, Kiichiro Ninomiya, et al.
Pageof 11